Showing results (191-200 of 226) with videos related to
Sort By:
Pageof 23
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 10, 2021
Analysis of frequency and severity of relapses in multiple sclerosis patients treated with cladribine tablets or placebo: The CLARITY and CLARITY Extension studiesNicola De Stefano, Maria Pia Sormani, Gavin Giovannoni, et al.The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|March 10, 2019
Examining the Effects of an Adolescent Pregnancy Prevention Program by Risk Profiles: A More Nuanced Approach to Program EvaluationSara A Vasilenko, Jill R Glassman, Kari C Kugler, et al.Annals of Neurology|January 31, 2007
Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trialJerry S Wolinsky, Ponnada A Narayana, Paul O'Connor, et al.Multiple Sclerosis and Related Disorders|October 23, 2017
Patient-reported outcomes in relapsing forms of MS: Real-world, global treatment experience with teriflunomide from the Teri-PRO studyPatricia K Coyle, Bhupendra Khatri, Keith R Edwards, et al.Multiple Sclerosis and Related Disorders|October 2, 2018
Patient-reported outcomes in patients with relapsing forms of MS switching to teriflunomide from other disease-modifying therapies: Results from the global Phase 4 Teri-PRO study in routine clinical practicePatricia K Coyle, Bhupendra Khatri, Keith R Edwards, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 18, 2023
Treatment of older patients with multiple sclerosis: Results of an International Delphi SurveyHayrettin Tumani, Patricia K Coyle, Claudia Cárcamo, et al.The Lancet. Neurology|February 8, 2014
Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trialThomas P Leist, Giancarlo Comi, Bruce A C Cree, et al.Molecular Ecology Resources|October 15, 2016
Development of a universal double-digest RAD sequencing approach for a group of nonmodel, ecologically and economically important insect and fish taxaM O Burford Reiskind, K Coyle, H V Daniels, et al.Multiple Sclerosis and Related Disorders|April 22, 2019
Teriflunomide real-world evidence: Global differences in the phase 4 Teri-PRO studyPatricia K Coyle, Bhupendra Khatri, Keith R Edwards, et al.International Journal of MS Care|March 7, 2018
Pregnancy Outcomes from the Branded Glatiramer Acetate Pregnancy DatabaseMagnhild Sandberg-Wollheim, Orit Neudorfer, Augusto Grinspan, et al.Pageof 23